Ardeparin Subcutaneous and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Ardeparin Subcutaneous and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Lithium ER
- Ardeparin Subcutaneous-Lithium Oral Solution
- Ardeparin Subcutaneous-Lithium Salts
- Ardeparin Subcutaneous-Lithium Syrup and Oral Solution
- Ardeparin Subcutaneous-Lithobid
- Ardeparin Subcutaneous-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Aredia
- Lithium Controlled-Release and Extended-Release Tablets-Arestin
- Lithium Controlled-Release and Extended-Release Tablets-Arestin eent
- Lithium Controlled-Release and Extended-Release Tablets-Arestin mucous membrane powder
- Lithium Controlled-Release and Extended-Release Tablets-Arformoterol
- Lithium Controlled-Release and Extended-Release Tablets-Arformoterol inhalation